In the Alabama case, a consumer took Reglan and developed tardive dyskinesia, which causes incurable and involuntary muscle movements, and accused Wyeth, which is now owned by Pfizer, of failing to warn of the risk of long-term use.
FORBES: Pfizer Wants Court To Rehear Generic Labeling Case And Avoid Tort Hell